Written Question·Department of Health and Social Care·UIN HL4567

Tabled: 26 October 2026

Question

To ask His Majesty's Government whether the holder of the UK marketing authorisation for Avastin (bevacizumab) has provided the Medicines and Healthcare products Regulatory Agency with the results of the MITO16b/MANGO-OV2/ENGOT-ov17 trial in recurrent ova